Amgen Inc.

AMG.DE·XETRA·Healthcare
Compare
429.60+6.10 (+1.44%)today
As of Nov 5, 12:32 PM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close423.50
Open423.95
Day range423.95429.60
52-week range267.60438.75
Off day high0.00%
Off 52-week high−2.09%
Volume132
Avg. volume (3M)505
Market cap232.26B
EPS (TTM)14.85
Forward P/E—
P/E ratio (TTM)28.93
Dividend yield2.17% (9.01)
Beta (5Y)0.42
Shares outstanding540.63M
Short interest—
Earnings dateNov 3, 2026 (est.)
Analyst target—
Profit margin22.95%

Against its peers

Compare in full ›
AMG.DE BIIB NVS 0R1F.IL 1801.HK REGN
Market cap 232.26B 37.61B 311.59B 137.59B 154.42B 96.28B
P/E (TTM) 28.9 110.2 31.5 17.3 116.5 20.6
Forward P/E — 15.6 16.6 — 34.9 13.2
Price/book 18.2 2.0 8.4 4.2 6.3 2.8
Dividend yield 2.17% — 2.87% 4.04% — 0.40%
1-year change +54.90% +62.35% +30.35% +34.05% −3.41% +43.87%
Today +1.44% +2.22% +3.59% +2.89% +4.12% −4.39%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Latest news

All AMG.DE news ›
The Globe and Mail·Negative

Scotiabank Remains a Buy on Amgen (AMGN)

Scotiabank analyst Louise Chen maintained a Buy rating on Amgen today and set a price target of $500.00. According to TipRanks, Chen is a 5-star analyst with an average return of 8.6% and a 54.51% success rate. Chen covers the Healthcare…

The Globe and Mail·Negative

Citi Sticks to Its Hold Rating for Amgen (AMGN)

Citi analyst Geoff Meacham maintained a Hold rating on Amgen today and set a price target of $405.00. According to TipRanks, Meacham is a 5-star analyst with an average return of 14.3% and a 58.75% success rate. Meacham covers the…

Minichart·Negative

Amgen Files Q3 2026 10-Q for Quarter Ended September 30

Minichart Amgen Files Q3 2026 10-Q for Quarter Ended September 30 Amgen Inc. (NASDAQ: AMGN) has filed its Form 10-Q for the quarterly period ended September 30, 2026, with the U.S. Securities and Exchange Commission, according to the…

MarketScreener·Positive

Amgen beats consensus and raises targets for 2026

marketscreener.com The California-based pharmaceutical company reported non-GAAP EPS up 14% to $6.45 for Q3 2026, well above the consensus of around $5.80, with its adjusted operating margin improving by 0.2% to 47.3%.Amgen's total revenue…

From the 4Search news index, newest first.

In the news

225mentions in 30 days
225with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance